DATA PENELITIAN RC3ID UNPAD (ONGOING)
Research Project Master List
Project Code | Working Group | Short Title | Long Title | Principal Investigator | Duration |
R-23 | Tuberculosis | EVIDENT | Evaluation and Demonstration of new TB diagnostics for Indonesia | Prof. Bachti Alisjahbana, dr.,SpPD-KPTI, PhD | 4 Years |
R-24 | Tuberculosis | PediPOT / INTERCEPT | A Prospective Observational Study on Paediatric TBM (PediPot) | Dewi Hawani Adiwar, dr., SpA(K) | 3 Years |
R-25 | Tuberculosis | TARGET 1.0 | Genomic Drug Sensitivity Testing with Targeted Next-Generation Sequencing (tNGS) for Drug-resistant Tuberculosis (DRTB) in West-Java, Indonesia | Prof. Dr. Arto Yuwono Soeroto, dr., SpPD-KP | 2 Years |
R-28 | Tuberculosis | Vaksin Trial M72 | A Phase 3, randomized, double-blind, placebo-controlled, multicenter, clinical trial to assess the prophylactic efficacy, safety, and immunogenicity of the investigational M72/AS01E-4 Mycobacterium tuberculosis (Mtb) vaccine when administered intramuscularly on a 0-,1-month schedule to adolescents and adults | Prof. Rovina Ruslami, dr., SpPD-KPTI, PhD | 5 Years |
R-29 | Tuberculosis | SMILE-TB | Shortened RegiMen for Drug-susceptIbLE TB in Children (SMILE-TB) | Prof. Rovina Ruslami, dr., SpPD-KPTI, PhD | 6 Years |
R-30 | DF-ONE | RECOVERY | Randomised Evaluation of COVID-19 Therapy (RECOVERY Trial): Uji Acak untuk COVID-19, Influenza, dan Pneumonia Komunitas | Prof. Bachti Alisjahbana, dr., SpPD-KPTI, PhD | 1 Years |
R-31 | Tuberculosis | PERSIST | PERSIST: Post-TB Lung Disease and Fungal Infections in Indonesia | Intan Mauli Warma Dewi, dr., MA, PhD | 5 Years |
R-32 | HIV | TAHOD | IeDEA ASIA-PACIFIC Research Collaboration : The TAHOD Continuum of Care (TAHOD-CC) Study | Rudi Wisaksana, dr., SpPD-KPTI, PhD | 1 Years |
R-33 | Tuberculosis | TARGET 2.0 | Validation of MGI TB tNGS in Indonesia | Bony Wiem Lestari, dr., MSc, PhD | 1 Years |
R-34 | Tuberculosis | SSTARLET | Shorter and Safer Treatment Regimens for Latent TB; An adaptive trial of TB preventive treatment | Prof. Rovina Ruslami, dr., SpPD-KPTI, PhD | 4 Years |
R-35 | Tuberculosis | PRIME | Plasma and breastmilk exposures to antituberculosis drugs In breastfeeding women an open–label, randomized, six-arm, single–dose, pharmacokinetic study | Prof. Rovina Ruslami, dr., SpPD-KPTI, PhD | 4 Years |
R-36 | DF-ONE | SUPERSEDE | Systems Immunology Approaches Biomarkers Susceptibility Dengue Fever | Silvita Fitri Riswari, dr., M.Kes, PhD | 4 Years |
R-37 | Tuberculosis | ADAPT Study | Acceptability of Dry Powder Inhaler Treatment by Pulmonary Tuberculosis Patients | Prof. Rovina Ruslami, dr., SpPD-KPTI, PhD | 1 Years |
R-44 | DF-ONE | ACCURATE | Development of ACute Undifferentiated feveR Triage (ACURATE) algorithm for rational antibiotic use and proper management of severe infection in the frontline | Prof. Bachti Alisjahbana, dr., SpPD-KPTI, PhD | 1 Years |
R-45 | Dengue | DISTRA | DISTRA: Dengue Illness Risk Stratification for Severe Outcome Study | Prof. Bachti Alisjahbana, dr., SpPD-KPTI, PhD | 1 Years |
R-47 | Tuberculosis | TB SPASIAL | Analisis Spasial Temporal Kasus Tuberkulosis dan Infeksi Laten Tuberkulosis di Provinsi Jawa Barat | Lika Apriani, dr., MSc, PhD | 2 month |
R-48 | HIV | DVR-Pilot | DVR Pilot Implementation Evaluation in Indonesia | Rudi Wisaksana, dr., SpPD-KPTI, PhD | 1 Years |
R-49 | Tuberculosis | AI-TB | Pengembangan Software berbasis AI pada Rontgent Dada dan Ultrasonografi Thorax untuk Deteksi Tuberkulosis dan Pneumonia | Bony Wiem Lestari, dr., MSc, PhD | 1 Years |
R-52 | DF-ONE | DIKTI - NISA | Dinamika Antibodi, keberagaman antigen MSP1, dan Parasitemia Awal pada Pasien Asimptomatik Plasmodium vivax di Daerah Endemis Malaria | Prof. Bachti Alisjahbana, dr., SpPD-KPTI, PhD | 2 Years |
R-53 | DF-ONE | EQUITY-SILVITA | Perbandingan Single-Round Infectious Particles (SRIPs)-based Neutralization Assay dan Plaque Reduction Neutralization Test (PRNT) untuk menentukan Correlate of Protection dan Risiko Dengue Berat | Silvita Fitri Riwari, dr., M. Kes, PhD | 1 Years |
R-54 | Tuberculosis Meningitis | DETOX | Adjunctive Dexamethasone for HIV Positive Patient with Toxoplasmosis: A Double-Blinded Randomized Controlled Trial/De-TOX Study (Dexamethasone for Cerebral Toxoplasmosis Study”) | Sofiati Dian, dr., SpS(K), M. Kes, PhD | 6 Years |
R-55 | Tuberculosis Meningitis | IMMENSE | Immune Responses in Tuberculous Meningitis Predicting Neuro-inflammation (IMMENS) | Sofiati Dian, dr., SpS(K), M. Kes, PhD | 3 Years |
R-56 | Tuberculosis | PROMISE | Post Tuberculosis Sequlae in Indonesia - Clinical Characteristics and Underlying Mechanisms | Sofiati Dian, dr.,SpS(K), M.Kes, PhD | 4 Years |
R-57 | Tuberculosis | DIAMANT | (DIAbetes Mellitus And Tuberculosis) | Bony Wiem Lestary, dr.,M.Sc, PhD | 2 Years |
R-58 | Tuberculosis | TB-TASA | Evaluasi kemampuan pelaksanaan Tes Diagnostik baru berbasis darah untuk Diagnosis Tuberkulosis | Prof. Bachti Alisjahbana, dr., SpPD-KPTI, PhD | 1 Years |
R-59 | Tuberculosis | ATTIS | Asymptomatic TB Transmission in Indonesia and South Africa | Prof. Bachti Alisjahbana, dr., SpPD-KPTI, PhD | 3 Years |
R-60 | Tuberculosis | Quantum Trial | Services Laboratory of Quantum Trial | Bony Wiem Lestary, dr.,M.Sc, PhD | 17 Months |
R-61 | TB-HIV | Bintuni Project | Kajian kebutuhan, Kapasitas dan Kelayakan Pengembangan Program Skrining Terpadu TB, HIV, Torch dan Helminthiasis di Kabupaten Teluk Bintuni | Prof. Bachti Alisjahbana, dr.,SpPD-KPTI, PhD | 1 Month |
R-62 | TB-HIV | TPT OSS Book | Consultancy on TB-HIV OSS & TPT Guideline | Yovita Hartantri, dr.,SpPD-KPTI | 40 Days |
| | LEN Pilot | LEN Pilot Development Consultacy | Rudi Wisaksana, dr., SpPD-KPTI, PhD | 5 Month |